semaglutide bad for kidneys Long-term kidney outcomes of in obesity and cardiovascular disease in the SELECT trial Semaglutide and Ozempic-like drugs may

Extremely high plasma glycine concentrations may lead to hyperglycinemia and, via catabolism, hyperammonemia, potentially causing neurological symptoms such as headache or confusion-though such events are exceedingly rare outside massive irrigant absorption

This risk is highest during the initial weeks of treatment or following dose escalation, when gastrointestinal symptoms are most pronounced

Eat easy-to-digest foods, so your colon is as empty as possible ahead of the procedure

Precautions: If you are pregnant, nursing, have a medical condition, have low blood sugar or are taking any medication, consult your physician before use

Ozempic (semaglutide) is a GLP-1 receptor agonist originally approved by the FDA in 2017 for the management of type 2 diabetes

Almost one-third of Americans and an estimated 650 million adults worldwide are classified as obese